MedTrace Logo

Biocollection of Patients With ANCA Associated Vasculitis

NCT05364892 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-08-07

No results posted yet for this study

Summary

As rare disease, vasculitis affects a small number of patients, the cohorts available in the literature are few and the pathophysiological mechanisms remain to be elucidated. The collection of standardized data within a patientheque as part of a multi-year follow-up will facilitate the study of the characteristics of these diseases. This may, in particular, address the main objective of identifying predictors of relapse, as well as secondary objectives for predictive factors of mortality, infectious, cardiovascular or neoplastic complications that affect the prognosis of vasculitis in order to establish a more appropriate management of the patients concerned.

Conditions

  • ANCA-associated Vasculitis

Interventions

OTHER

Blood samples (80 mL)

Blood samples (80 mL) at inclusion, once a year for 5 years, and if relapse or change of treatment

OTHER

Fecal samples

Fecal samples at inclusion

OTHER

Urinary sample (20-40 mL)

Urinary samples at inclusion, once a year for 5 years, and if relapse or change of treatment

OTHER

Questionnaires

Questionnaires at inclusion, once a year for 5 years, and if relapse or change of treatment

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-27
Primary Completion
2032-10-27
Completion
2032-10-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05364892 on ClinicalTrials.gov